Picture of SSY logo

2005 SSY Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSuper Stock

Momentum

Relative Strength (%)
1m+5.88%
3m+1.95%
6m+2.38%
1yr-4.94%
Volume Change (%)
10d/3m+63.42%
Price vs... (%)
52w High-13.73%
50d MA+8.35%
200d MA+8.39%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)8.83
PEG Ratio (f)0.56
EPS Growth (f)18.87%
Dividend Yield (f)3.53%
Valuation (ttm)IndustryMarket
Price to Book Value2.1
Price to Tang. Book2.52
Price to Free Cashflown/a
Price to Sales2.25
EV to EBITDA8.09

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital17.35%
Return on Equity20.06%
Operating Margin25.36%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueHK$m4,635.684,260.95,356.766,434.026,463.017,582.978,825.339.1%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+10.01-40.34+29.17+45.49+17.41+19.28+17.99n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of SSY EPS forecast chart

Profile Summary

SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
September 28th, 2004
Public Since
December 20th, 2005
No. of Employees
5,600
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
hk flag iconStock Exchange of Hong Kong Limited
Shares in Issue
2,969,043,385

2005 Share Price Performance

Upcoming Events for 2005

SSY Group Ltd Annual Shareholders Meeting

Dividend For 2005.HK - 0.1000 HKD

Half Year 2024 SSY Group Ltd Earnings Release

Similar to 2005

Picture of 3D Medicines logo

3D Medicines

hk flag iconStock Exchange of Hong Kong Limited

Picture of 3SBio logo

3SBio

hk flag iconStock Exchange of Hong Kong Limited

Picture of AIM Vaccine Co logo

AIM Vaccine Co

hk flag iconStock Exchange of Hong Kong Limited

Picture of Ascletis Pharma logo

Ascletis Pharma

hk flag iconStock Exchange of Hong Kong Limited

Picture of Asymchem Laboratories Tianjin Co logo

Asymchem Laboratories Tianjin Co

hk flag iconStock Exchange of Hong Kong Limited

FAQ